Brain clearance of protein aggregates: a close-up on astrocytes

• Published in: Molecular neurodegeneration Vol. 19; no. 1; pp. 5 - 18
• Main Authors: Giusti, Veronica, Kaur, Gurkirat, Giusto, Elena, Civiero, Laura
• Format: Journal Article
• Language: English
• Published: London BioMed Central 16.01.2024; BioMed Central Ltd; BMC
• Subjects: alpha-Synuclein - metabolism; Alzheimer's disease; Amyloid; Amyloid proteins; Astrocytes; Astrocytes - metabolism; Autophagy; Biomedical and Life Sciences; Biomedicine; Brain; Brain - metabolism; Clearance; Dementia; Enzymes; Fibrils; Glycoproteins; Humans; Kinases; Microglia; Microglia - metabolism; Molecular Medicine; Molecular modelling; Nervous system diseases; Neurodegenerative diseases; Neurodegenerative Diseases - metabolism; Neurology; Neurosciences; Pathology; Protein Aggregates; Protein folding; Proteins; Review; Synuclein; Tau; Tau protein; Toxicity; α-Synuclein; α-Synuclein; Tau; Clearance; Astrocytes; Amyloid proteins
• ISSN: 1750-1326; 1750-1326
• DOI: 10.1186/s13024-024-00703-1

Protein misfolding and accumulation defines a prevailing feature of many neurodegenerative disorders, finally resulting in the formation of toxic intra- and extracellular aggregates. Intracellular aggregates can enter the extracellular space and be subsequently transferred among different cell types, thus spreading between connected brain districts. Although microglia perform a predominant role in the removal of extracellular aggregated proteins, mounting evidence suggests that astrocytes actively contribute to the clearing process. However, the molecular mechanisms used by astrocytes to remove misfolded proteins are still largely unknown. Here we first provide a brief overview of the progressive transition from soluble monomers to insoluble fibrils that characterizes amyloid proteins, referring to α-Synuclein and Tau as archetypical examples. We then highlight the mechanisms at the basis of astrocyte-mediated clearance with a focus on their potential ability to recognize, collect, internalize and digest extracellular protein aggregates. Finally, we explore the potential of targeting astrocyte-mediated clearance as a future therapeutic approach for the treatment of neurodegenerative disorders characterized by protein misfolding and accumulation.